Friday, July 31, 2026

Diplomatic Fail: Ally Admits North Korea Is Now A Nuclear Power As US Focus Shifts To China

South Korea's diplomatic push on North Korea's nuclear capabilities at the UN falters, as U.S. interest wanes amid deepening China-North Korea ties.

AITRICS establishes first AI ethics checklist in healthcare

AITRICS develops the first AI ethics checklist for healthcare, ensuring compliance with ethical standards in medical AI applications.

SHADOWS ON THE WAVES : Deciphering The Strategic Signal Of Kim’s Latest Naval Strike

Kim Jong Un supervised a sea-to-ground missile test launch from a ship, as reported by North Korea's Rodong Sinmun.

Tag: Yuflyma

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

FDA Ruling Paves Way for Pharmacy Substitution of Yuflyma for Humira

Celltrion's Yuflyma receives FDA approval for interchangeability with Humira, boosting market confidence and distribution in the U.S.

Top News

- Our Sponsors Ad -

Follow us